Hyalto Plus Injection (Sodium Hyaluronate)

Adult administration

Typically, 1 syringe is administered once a week for 3 consecutive weeks into the knee joint or shoulder joint (shoulder joint space, subacromial bursa, or tendon sheath of the biceps brachii), but the frequency of administration should be adjusted according to symptoms. This drug is administered intra-articularly, so it must be performed under strict aseptic conditions.

This drug is an injection that helps relieve intra-articular inflammation and provides lubrication through sodium hyaluronate. It should not be used in patients who have had allergic reactions to any of the ingredients contained in this drug. Patients who are allergic to other medications or have liver function issues should use this drug with more caution. Additionally, it is important to check and treat any skin diseases or infections at the injection site before administering this drug. After receiving the injection, there may be allergic reactions such as swelling of the face or around the eyes, rash, or itching, and if these symptoms occur, the administration should be stopped immediately. Temporary pain, swelling, redness, or warmth may appear at the injected joint site, so careful observation is required after administration. Rarely, systemic symptoms such as nausea, vomiting, or fever may occur. In cases of severe inflammation in the joint, this drug may worsen inflammation, so it is advisable to relieve inflammation first before using it. After injection, care should be taken to stabilize the joint area and avoid overexertion. During injection, maintain a sterile environment to reduce the risk of infection and ensure the drug does not leak outside of the joint space. This drug is not intended for intravenous injection or ophthalmic use, and a needle gauge of 22-23 is appropriate. Also, it should not be used in conjunction with certain disinfectants, as this may cause drug precipitation. Women who are pregnant or may become pregnant should only use this drug after carefully considering the need for treatment and the associated risks, as its safety has not been established. Nursing mothers should avoid breastfeeding during treatment, as this drug may be transmitted through breast milk. The safety of this drug in children has not been sufficiently confirmed, so it should only be used carefully in cases where necessary. Elderly patients may have decreased physical function, so special caution should be exercised when using this drug.

Serious side effects

Shock symptoms

Mild side effects

• Swelling (facial, eyelid, etc.)
• facial flushing
• rash
• urticaria
• itching
• pain
• swelling
• redness
• warmth
• severe localized pressure sensation

This drug should be stored in a sealed container to prevent air or moisture from entering, and it is important to store it at a controlled temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the effectiveness of the drug for a longer period.

Appearance

A colorless, transparent, and viscous liquid contained in a glass or plastic tube sealed with rubber stoppers (part of a pre-filled syringe system)

Package unit

2 milliliters/pre-filled syringe (2ml x 3 syringes)